Company: CYTK
Filing Date: 2025-03-31
Form Type: PRE 14A
Source: 0001140361-25-011212
Chunk: 98

Company: CYTOKINETICS INC
Filing Date: 2025-03-31
Form: PRE 14A
Chunk 98
---
 has one year following resignation to exercise vested options. Non-employee directors with five years or more of service but less than ten years of service on the Board of Directors have two years following resignation to exercise vested options, and those non-employee directors with ten years or more of service have three years following resignation to exercise vested options. The terms of stock option award grants after March 2024 reflect the foregoing. This approved modification was accounted for under Topic 718 and resulted in an additional $1.1 million of expense in 2024.

| Cytokinetics, Inc.|2025 Proxy Statement |     | 67 |

TABLE OF CONTENTS Director Compensation

Director Compensation Table for 2024 Employee directors receive no separate compensation for service as a member of the Board of Directors. The following table summarizes the total compensation for 2024 earned by our non-employee Directors.

| Name           |     |  Fees Earned or 
 Paid in Cash(1) |     |    Option 
 Awards(2) |     |     Stock 
 Awards(3) |     |    Total |
| Ms. Bhanji     |     |         $65,000 |     |  $239,826 |     |  $219,978 |     | $524,804 |
| Mr. Costa      |     |         $82,500 |     |  $239,826 |     |  $219,978 |     | $542,304 |
| Dr. Harrington |     |         $58,333 |     |  $239,826 |     |  $219,978 |     | $518,137 |
| Dr. Henderson  |     |        $116,250 |     |  $239,826 |     |  $219,978 |     | $576,054 |
| Dr. Kaye       |     |         $72,917 |     |  $239,826 |     |  $219,978 |     | $532,720 |
| Ms. Parshall   |     |         $89,167 |     |  $239,826 |     |  $219,978 |     | $548,970 |
| Mr. Smith      |     |         $37,564 |     |        $— |     |        $— |     |  $37,564 |
| Dr. Wierenga   |     |         $85,833 |     |  $239,826 |     |  $219,978